M-PREDROL Drug Patent Profile
✉ Email this page to a colleague
When do M-predrol patents expire, and when can generic versions of M-predrol launch?
M-predrol is a drug marketed by Bel Mar and is included in two NDAs.
The generic ingredient in M-PREDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for M-predrol
A generic version of M-PREDROL was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for M-PREDROL?
- What are the global sales for M-PREDROL?
- What is Average Wholesale Price for M-PREDROL?
Summary for M-PREDROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 4,322 |
| DailyMed Link: | M-PREDROL at DailyMed |
US Patents and Regulatory Information for M-PREDROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bel Mar | M-PREDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 086666-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bel Mar | M-PREDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 087135-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
